Welcome to the e-CCO Library!

OP13: Molecular response to ustekinumab in moderate-to-severe ulcerative colitis by serum protein and biopsy gene expression analysis: Results from the UNIFI Phase 3 induction study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Li*1, F. Yang1, K. Hayden1, D. Strawn1, E. Wadman1, S. Bhagat1, C. Marano1, J. R. Friedman1

Created: Friday, 22 February 2019, 9:41 AM
OP13: Mucosal organoids capture Innate Lymphoid Cells (ILC) tissue-specific development and reveal that Inflammatory Bowel Disease-associated ILC modulate intestinal remodelling
Year: 2021
Source: ECCO'21 Virtual
Authors: Jowett, G.M.(1);Read, E.(1);Norman, M.D.(2);Arevalo, P.A.(1);Vilà González, M.(3);Roberts, L.(4);Vallier, L.(3);Curtis, M.(1);Lord, G.(5);Gentleman, E.(2);Neves, J.F.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP13: Postoperative Crohn's disease recurrence: unanswered questions and future directions in diagnosis, pathophysiology, prevention and treatment. Conclusions from the 8th ECCO Scientific workshop.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Riviere, P.(1)*;Dragoni, G.(2);Allez, M.(3);Allocca, M.(4);Arebi, N.(5);Bemelman, W.(6);Bislenghi, G.(7);Brown, S.(8);Carvello, M.(9);De Vries, A.(10);Domenech, E.(11);Hammoudi, N.(3);Kapizioni, C.(12);Kotze, P.G.(13);Mañosa, M.(11);Myrelid, P.(14);Oliveira-Cunha, M.(15);Noor, N.N.(16);Pellino, G.(17);Pouillon, L.(18);Savarino, E.(19);Verstockt, B.(20);Panis, Y.(21);Ferrante, M.(20);
Created: Friday, 14 July 2023, 10:43 AM
OP14 Risk of colorectal cancer diagnosis and colorectal cancer mortality in Crohn’s disease: A Scandinavian population-based cohort study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

O. Olen1, R. Erichsen2, M.C. Sachs1, L. Pedersen2, J. Halfvarson3, J. Askling1, A. Ekbom1, H.T. Sørensen2, J.F. Ludvigsson4

Created: Thursday, 30 January 2020, 10:12 AM
OP14: Extracellular RNAs as liquid biopsy non-invasive biomarker in IBD
Year: 2021
Source: ECCO'21 Virtual
Authors: Verstockt., B.(1,2);Verstockt, S.(2);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP14: Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. J. Sandborn*1,1, S. Schreiber2, S. D. Lee3, J. O. Lindsay4, X. Hebuterne5, W. Zhou6, F. Cataldi6, A. P. Lacerda6, B. Huang6, W. Xie6, E. V. Loftus Jr7

Created: Friday, 22 February 2019, 9:41 AM
OP14: Interpreting genome-wide association studies of Inflammatory Bowel Disease through the lens of single-cell sequencing
Year: 2022
Source: ECCO'22
Authors: Krzak, M.(1);Taylor, L.(1);Alegbe, T.(1);Ghouraba, M.(1);Strickland, M.(1);Przybilla, M.(1);Noell, G.(1);Iyer, V.(1);Cheam, A.X.(2);Matte, J.(1);Parkes, M.(3);McIntyre, R.(1);Raine, T.(3);Anderson, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
OP14: Prevention of postoperative recurrence of Crohn's disease with vedolizumab: First results of the prospective placebo-controlled randomised trial REPREVIO
Year: 2023
Source: ECCO’23 Copenhagen
Authors: D'Haens, G.(1)*;Taxonera, C.(2);Lopez-Sanroman, A.(3);Nos Mateu, P.(4);Danese, S.(5);Armuzzi, A.(6);Roblin, X.(7);Peyrin-Biroulet, L.(8);West, R.(9);Witteman, B.(10);Duijvestein, M.(11);Gecse, K.(1);Hulshoff, M.(1);Mostafavi, N.(1);Clasquin, E.(1);Bouhnik, Y.(12);Laharie, D.(13);
Created: Friday, 14 July 2023, 10:43 AM
OP15 Multi-omic data integration with network analysis reveals underlying molecular mechanisms driving Crohn’s disease heterogeneity
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Sudhakar1,2,3, B. Verstockt1,4, J. Cremer5, S. Verstockt1, T. Korcsmaros2,3, M. Ferrante1,4, S. Vermeire1,4

Created: Thursday, 30 January 2020, 10:12 AM
OP15: A new simplified histology artificial intelligence system for accurate assessment of remission in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Villanacci, V.(1);Parigi, T.L.(2,3);Del Amor, R.(4);Mesguer Esbrì, P.(4);Gui, X.(5);Bazarova, A.(6);Bhandari, P.(7);Bisschops, R.(8);Danese, S.(9);De Hertogh, G.(8);Ferraz, J.G.(10);Götz, M.(11);Grisan, E.(12);Hayee, B.(13);Kiesslich, R.(14);Lazarev, M.(15);Mandelli, G.(1);Monica, M.A.T.(1);Panaccione, R.(10);Parra-Blanco, A.(16);Pastorelli, L.(17);Rath, T.(18);Røyset, E.S.(19);Shivaji, U.(3);Tontini, G.E.(17);Vieth, M.(20);Zardo, D.(21);Ghosh, S.(22);Naranjo, V.(4);Iacucci, M.(3);
Created: Friday, 11 February 2022, 3:52 PM
OP15: Cost analysis in a prospective European population-based inception cohort: is there a cost-saving effect of biological therapy?
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Burisch*1, H. Vardi2, D. Schwartz3, Z. Krznaric4, P. L. Lakatos5, M. Fumery6, L. Kupcinskas7, F. Magro8, E. Belousova9, P. Oksanen10, N. Arebi11, E. Langholz12, S. Turcan13, R. D’Inca14, V. Hernandez15, D. Valpiani16, Z. Vegh5, M. Giannotta17, K. H. Katsanos18, D. Duricova19, K. R. Nielsen20, H. A. L. Kievit21, P. Ellul22, R. Salupere23, A. Goldis24, I. Kaimakliotis25, N. Pedersen26, V. Andersen27, J. Halfvarson28, S. Sebastian29, J. F. Dahlerup30, P. Munkholm1, S. Odes3, Epi-IBD

Created: Friday, 22 February 2019, 9:41 AM
OP15: Cyclic exclusive enteral nutrition to maintain longterm drug-free remission in Paediatric Crohn’s Disease: The CD HOPE study of the GETAID pédiatrique
Year: 2021
Source: ECCO'21 Virtual
Authors: Pigneur Arnaud, B.(1);Martinez-Vinson, C.(2);Bourmaud, A.(3);Swellen, G.(4);Duclaux-Loras, R.(5);Hugot, J.P.(2);Roman, C.(6);Dumant, C.(7);Spyckerelle, C.(8);Guinard Samuel, V.(9);Willot, S.(10);Dupont, C.(11);Breton, A.(12);Caron, N.(13);Chaillou, E.(14);Rebouissoux, L.(15);Triolo, V.(16);Bertrand, V.(17);Pages, J.(3);Djamal-Dine, D.(18);Bonneton, M.(19);Uhlen, S.(20);Catteau, N.(21);Coopman, S.(22);Viala, J.(2);Ruemmele, F.M.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP15: Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Danese, S.(1)*;Afif, W.(2);Abreu, M.(3);Sandborn, W.(4);Miao, Y.(5);Zhang, H.(5);Panaccione, R.(6);Hisamatsu, T.(7);Scherl, E.(8);Leong, R.(9);Rowbotham, D.(10);Arasaradnam, R.(11);Peyrin-Biroulet, L.(12);Sands, B.(13);Marano, C.(5);
Created: Friday, 14 July 2023, 10:43 AM
OP16 Influence of early life factors on the development of intestinal microbiota of infants born to mothers with and without IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Guedelha Sabino1,2,3, L. Tarassishin1, C. Eisele1, A. Barré1, M. Dubinsky4, J. Stone5, N. Nair1, A. Debebe1, K. Hawkins1, A. Rendon1, J. Hu1, J.F. Colombel3, P. Inga1, J. Torres3,6

Created: Thursday, 30 January 2020, 10:12 AM
OP16: A randomised, multi-centre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild-to-moderate ulcerative colitis: efficacy results
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Bloom*1, T. Iqbal2, C. Nwokolo3, M. Smith4, D. O’Donoghue5, J. Hall6, B. Dzyngel6

Created: Friday, 22 February 2019, 9:41 AM
OP16: Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn’s Disease: A Multi-center Study from the Porto Group of ESPGHAN
Year: 2021
Source: ECCO'21 Virtual
Authors: Berger, T.(1);Miin Lee, H.(2);Ramasamy Padmanaban, L.(2);Wine, E.(3);Yerushalmi, A.(4);Hojsak, I.(5);Bronski, J.(6);Serban, D.(7);Yogev, D.(8);Ledder, O.(8);Lionetti, P.(9);Scarrallo, L.(9);Gasparetto, M.(10);Croft, N.(10);Miele, E.(11);Staiano, A.(11);Meredith, J.(12);Aloi, M.(13);Alvisi, P.(14);Urlep, D.(15);Weiss, B.(1);Knudsen, M.(16);Matar, M.(17);Manuel Navas-López, V.(18);Romano, C.(19);Dipasquale, V.(19);Norsa, L.(20);Kolho, K.L.(21);Shamir, R.(17);Shouval, D.(17)
Created: Wednesday, 2 June 2021, 4:12 PM
OP16: Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Peyrin-Biroulet, L.(1)*;Parkes, G.(2);Rodríguez, C.(3);Siffledeen, J.(4);Wright, J.(5);Broide, E.(6);Ford, S.(7);Lacerda, A.P.(7);Oomen, J.(7);Garrison, A.(7);Berg, S.(7);Rubin, D.T.(8);
Created: Friday, 14 July 2023, 10:43 AM
OP16: The first virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic remission in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Iacucci, M.(1);Cannatelli, R.(2);Parigi, T.L.(1,3);Buda, A.(4);Labarile, N.(5);Nardone, O.M.(6);Tontini, G.E.(7);Rimondi, A.(7);Bazarova, A.(8);Bhandari, P.(9);Bisschops, R.(10);De Hertogh, G.(10);Del Amor, R.(11);Ferraz, J.G.(12);Goetz, M.(13);Gui, X.(14);Hayee, B.(15);Kiesslich, R.(16);Lazarev, M.(17);Naranjo, V.(11);Panaccione, R.(12);Parra-Blanco, A.(18);Pastorelli, L.(19);Rath, T.(20);Røyset, E.S.(21);Vieth, M.(22);Villanacci, V.(23);Zardo, D.(24);Ghosh, S.(25);Grisan, E.(26,27);
Created: Friday, 11 February 2022, 3:52 PM
OP17 Protein intakes and risk of inflammatory bowel disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Dong1, Y. Mahamat-Saleh2, A. Racine3, P. Jantchou4, S. Chan6, A. Hart5, F. Carbonnel3, M.C. Boutron-Ruault2

Created: Thursday, 30 January 2020, 10:12 AM
OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Huang1, H. Irizar2, R. Kosoy3, W-m. Song3, A. Dinarzo3, K. Hao3, J. Rogers4, A. Atreja4, M. Mahajan3, A. Stojmirovic5, J. Perrigoue5, C. Brodmerkel5, S. Plevy5, J. Friedman5, J-F. Colombel4, M. Dubinsky4, B. Sands4, E. Schadt3, A. Kasarskis3, B. Losic3, C. Argmann3, M. Suarez-Farinas1,3

Created: Friday, 22 February 2019, 9:41 AM